Fifth Third Bancorp’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,000
| Closed | -$128K | – | 2682 |
|
|
2025
Q2 | $128K | Sell |
1,000
-2,221
| -69% | -$231K | ﹤0.01% | 1076 |
|
|
2025
Q1 | $285K | Buy |
3,221
+146
| +5% | +$14.2K | ﹤0.01% | 885 |
|
|
2024
Q4 | $268K | Buy |
3,075
+2,075
| +208% | +$190K | ﹤0.01% | 898 |
|
|
2024
Q3 | $92.5K | Hold |
1,000
| – | – | ﹤0.01% | 1205 |
|
|
2024
Q2 | $108K | Hold |
1,000
| – | – | ﹤0.01% | 1122 |
|
|
2024
Q1 | $94.9K | Hold |
1,000
| – | – | ﹤0.01% | 1138 |
|
|
2023
Q4 | $92.2K | Hold |
1,000
| – | – | ﹤0.01% | 1174 |
|
|
2023
Q3 | $50.2K | Hold |
1,000
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q2 | $63.2K | Hold |
1,000
| – | – | ﹤0.01% | 1286 |
|
|
2023
Q1 | $45K | Hold |
1,000
| – | – | ﹤0.01% | 1471 |
|
|
2022
Q4 | $43.8K | Hold |
1,000
| – | – | ﹤0.01% | 1381 |
|
|
2022
Q3 | $66K | Hold |
1,000
| – | – | ﹤0.01% | 1219 |
|
|
2022
Q2 | $51K | Hold |
1,000
| – | – | ﹤0.01% | 1346 |
|
|
2022
Q1 | $64K | Sell |
1,000
-71
| -7% | -$5.1K | ﹤0.01% | 1356 |
|
|
2021
Q4 | $115K | Sell |
1,071
-68
| -6% | -$7.11K | ﹤0.01% | 1194 |
|
|
2021
Q3 | $117K | Sell |
1,139
-53
| -4% | -$4.94K | ﹤0.01% | 1123 |
|
|
2021
Q2 | $105K | Sell |
1,192
-91
| -7% | -$8.34K | ﹤0.01% | 1171 |
|
|
2021
Q1 | $125K | Sell |
1,283
-161
| -11% | -$16.1K | ﹤0.01% | 1085 |
|
|
2020
Q4 | $162K | Sell |
1,444
-2,661
| -65% | -$280K | ﹤0.01% | 995 |
|
|
2020
Q3 | $381K | Sell |
4,105
-685
| -14% | -$52.8K | ﹤0.01% | 689 |
|
|
2020
Q2 | $374K | Buy |
+4,790
| New | +$324K | ﹤0.01% | 692 |
|
|
2018
Q4 | – | Sell |
-82
| Closed | -$6K | – | 2224 |
|
|
2018
Q3 | $6K | Sell |
82
-71
| -46% | -$4.93K | ﹤0.01% | 1937 |
|
|
2018
Q2 | $10K | Hold |
153
| – | – | ﹤0.01% | 1875 |
|
|
2018
Q1 | $14K | Hold |
153
| – | – | ﹤0.01% | 1780 |
|
|
2017
Q4 | $12K | Sell |
153
-523
| -77% | -$36.8K | ﹤0.01% | 1764 |
|
|
2017
Q3 | $47K | Buy |
+676
| New | +$36.1K | ﹤0.01% | 1298 |
|
Other funds holding BPMC
IA
HNB
Fifth Third Bancorp's BPMC Position: Q3 2025 in Review
Fifth Third Bancorp sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,000 shares — an estimated $128K sold.
Fifth Third Bancorp first reported a position in BPMC in Q3 2017 and held it in 26 quarters. The position peaked at $381K in Q3 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Fifth Third Bancorp reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Fifth Third Bancorp sold 1,000 Blueprint Medicines shares in Q3 2025, an estimated $128K.
- Fifth Third Bancorp first reported a position in Blueprint Medicines in Q3 2017 and held it in 26 quarters.
- Fifth Third Bancorp's Blueprint Medicines position peaked at $381K in Q3 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.